recmAb Biosimilar Portfolio

About Abeomics

Abeomics is a privately held biotechnology company providing critical research reagents and custom services to accelerate drug discovery and biomedical research. The company leverages recombinant antibody technology to produce biosimilars of key therapeutic antibodies like Trastuzumab, alongside a broad portfolio of tools targeting pathways in immunology, oncology, and innate immunity. Its business model combines product sales of research-grade antibodies and cell lines with fee-for-service CRO work in screening, cell line development, and protein production. Founded by Dr. Gita Singh, the company is positioned as a specialized supplier in the large and growing research tools market.

Therapeutic Areas